Blitzy
Autonomous software development platform that deploys thousands of AI agents to complete enterprise codebases
$200MGrowth
Role not disclosedActivity from announced rounds
NFX is the investment firm identified through founding partner Gigi Levi-Weiss in Remepy’s announcement and through Omri Amirav Drory’s TwoStep relationship.
Remepy combines medicines with therapeutic applications. TwoStep develops targeted cancer therapies, while Starcloud develops orbital computing. The event records identify the firm without inferring a particular fund.